Emit II Plus Cocaine Metabolite Assay

Enzyme Immunoassay, Cocaine And Cocaine Metabolites

SIEMENS HEALTHCARE DIAGNOSTICS INC.

The following data is part of a premarket notification filed by Siemens Healthcare Diagnostics Inc. with the FDA for Emit Ii Plus Cocaine Metabolite Assay.

Pre-market Notification Details

Device IDK170293
510k NumberK170293
Device Name:Emit II Plus Cocaine Metabolite Assay
ClassificationEnzyme Immunoassay, Cocaine And Cocaine Metabolites
Applicant SIEMENS HEALTHCARE DIAGNOSTICS INC. P.O. BOX 6101 M/S 514 Newark,  DE  19714 -6101
ContactAlan Haley
CorrespondentAlan Haley
SIEMENS HEALTHCARE DIAGNOSTICS INC. P.O. BOX 6101 M/S 514 Newark,  DE  19714 -6101
Product CodeDIO  
CFR Regulation Number862.3250 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2017-01-31
Decision Date2017-10-25
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00842768014390 K170293 000
00842768001949 K170293 000
00842768001932 K170293 000
00842768023415 K170293 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.